rabeprazole has been researched along with Kidney Diseases in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, M | 1 |
| Tada, H | 1 |
| Satoh, S | 1 |
| Habuchi, T | 1 |
| Suzuki, T | 1 |
1 trial available for rabeprazole and Kidney Diseases
| Article | Year |
|---|---|
Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Chromatog | 2006 |